Under eye treatment Correction: A Precise Clinical Approach

Why the Tear Trough is High-Risk

The tear trough area presents unique challenges for both treatment and correction. The skin is extraordinarily thin, as thin as 0.5 millimetres in some patients, and the area is underlain by delicate orbital structures, lymphatic vessels, and the orbicularis oculi muscle. There is minimal subcutaneous fat to provide natural volume and containment for injected material. The area is highly mobile; every blink moves the tissue, and every change in facial expression or head position alters the mechanical dynamics of the under eye skin. The tear trough is also highly visible. Even small asymmetries, irregularities, or discolourations are immediately apparent to the patient and to observers.

The vasculature of the under eye region is extensive. Large blood vessels run through this area, and inadvertent vascular injection can cause tissue necrosis and permanent scarring. The lymphatic system is also highly active here; fluid easily accumulates, and the congestion can persist for months even after the volume treatment itself is resolved. The under eye area is more prone to inflammatory responses than other facial areas, and some patients experience marked swelling, bruising, or inflammatory reactions to volume treatment that would be minimal elsewhere on the face.

Additionally, the under eye area is constantly in a state of mild inflammation and fluid retention due to the lymphatic and vascular dynamics. This means that distinguishing between swelling caused by new volume treatment and the patient’s baseline lymphatic congestion is technically challenging. Some patients experience apparent improvement in the dark circles and hollowness immediately after under eye treatment injection, only to discover months later that the swelling has become pronounced and the original problem has actually worsened. This delayed negative response is one of the most common reasons patients seek under eye treatment correction.

Anatomy of the Tear Trough Region

The tear trough is the groove that runs from the inner corner of the eye downward and outward towards the upper cheek. It is formed by the junction of the orbicularis oculi muscle, the orbital fat pads, and the thin skin that overlies these structures. Just deep to the tear trough lies the periosteum of the maxillary bone. The tear trough is also adjacent to the medial canthus, the inner corner of the eye where the upper and lower lids meet, and this area contains important structures including the lacrimal caruncle and the lacrimal drainage system.

When volume treatment is injected into the tear trough, the depth of placement is critical. If placed too superficially, volume treatment can be visible through the thin skin, creating a bumpy, irregular, or discoloured appearance. This is particularly likely with hyaluronic acid volume treatments, which can cause a blue grey discolouration known as the Tyndall effect when located in the superficial dermis. If placed too deeply, volume treatment can track along the planes of the orbital muscle or settle into the space beneath the orbital rim, where it may not provide the volume where it is intended and may instead cause hollowness or asymmetry above the inner lid. Some practitioners inject directly into the periosteal plane, which can be effective but carries a higher risk of reactive swelling.

The tear trough region is also the junction between the mobile eyelid and the relatively stationary upper cheek. Treatment placement must account for these different zones of mobility. Volume treatment intended to add volume to the tear trough itself must move with the eyelid. Volume treatment intended to smooth the transition between the tear trough and the cheek must be placed lower and laterally. This anatomical complexity means that tear trough augmentation is one of the most technically sensitive areas for treatment injection, and errors in depth, volume, or placement have visible and sometimes persistent consequences.

Common Problems After Under eye treatment

Persistent swelling is the most frequent complaint after under eye treatment treatment. Swelling is expected for the first week or two after injection, but in some patients the swelling persists for months or continues to worsen. The swelling may be due to the volume treatment itself triggering a chronic inflammatory response, or it may be due to the volume treatment exacerbating the patient’s underlying lymphatic congestion. Some patients discover that the volume treatment has created a situation where fluid accumulates more readily, and the under eye area appears puffy even on mornings when other parts of the face appear normal. This kind of persistent oedema can be more bothersome than the original concern that prompted the volume treatment.

Puffiness and “bags” are distinct from swelling. True puffiness results from localised volume of volume treatment that has settled into the tear trough or just below it. The volume treatment adds volume where the patient may not have wanted it, creating a puffy, tired appearance. Some patients who sought to correct dark circles and hollowness find that the volume treatment has improved the hollow appearance but created a puffy appearance in its place, and they are uncertain whether the trade off is worthwhile. Puffiness can also result from reactive swelling that settles into a chronic mild oedema; the tissue becomes somewhat thickened and loses its natural tautness.

Discolouration is another significant problem. The Tyndall effect causes a blue grey or blue brown discolouration that is visible through the thin under eye skin. This occurs when hyaluronic acid volume treatment is placed too superficially. The discolouration can persist for months and is difficult to treat without dissolving the volume treatment. Some patients also report that the discolouration makes their under eye appearance worse than before treatment; instead of a dark shadow from hollowness, they now have a dark shadow from discoloured volume treatment. Dark circles caused by vascular prominence and true pigmentation can also appear worse after under eye treatment if the volume treatment has shifted the skin or changed how light reflects off the area.

Texture irregularities are also common. Nodules, bumps, or areas of roughness may develop in the under eye skin, particularly if some of the volume treatment has migrated superficially. These are sometimes visible and sometimes only palpable. They may not be apparent at rest but become visible when the patient is in certain lighting, when laughing, or when the eyes are closed. Some textural irregularities are temporary and resolve as the volume treatment integrates or is partially absorbed. Others persist and become a source of ongoing concern for the patient.

Assessment: Distinguishing Volume from Fluid Retention

The assessment of under eye treatment problems begins by understanding what is actually present: Is the problem true volume of volume treatment that has been placed or persisted in the wrong location? Is it fluid retention and reactive swelling triggered or worsened by the volume treatment? Is it a combination of both? This distinction is essential because treatment pathways differ significantly depending on the underlying cause.

True volume treatment volume appears consistent from day to day and with changes in the patient’s activity level, sleep, and hydration. Fluid retention, by contrast, varies. It is typically worse in the morning or after the patient has been lying flat for several hours, and it may improve throughout the day or after activity that stimulates lymphatic drainage. It is worse during hormonal cycles in some patients, and it may fluctuate with diet, salt intake, or systemic hydration. The clinician asks the patient detailed questions about these patterns: Is the puffiness the same every morning, or does it vary? Does it improve during the day? Does it get worse or better with exercise, elevation, or changes in salt intake? Does it correlate with the menstrual cycle?

Visual assessment also helps differentiate the two. Volume treatment volume creates localised bulging or thickness that is visible even when the patient is at rest and upright. Fluid retention creates a soft, compressible swelling that may change with position or activity. Palpation is particularly helpful. The clinician gently presses the under eye tissue to feel whether there is true volume of dense material, or whether the tissue is soft and oedematous. Oedematous tissue blanches under pressure and refills quickly. Volume treatment material is firmer and does not compress easily. Gentle massage applied during the assessment can help determine whether the puffiness improves with lymphatic drainage stimulation, suggesting that fluid retention is a significant component.

Assessing Depth of Placement and volume treatment Distribution

The depth and location of existing volume treatment within the under eye region directly determines what correction approach is most appropriate. Volume treatment placed very superficially, in the dermis, is more likely to cause discolouration and textural problems. It is more accessible to dissolution if needed. Volume treatment placed in the mid dermal or supraperiosteal plane may create less visible irregularity but may contribute more to swelling and puffiness. Very deep volume treatment, placed near the bone, may not be visible at all but may cause changes in the contour or texture of the eye area that the patient perceives as “wrong” without being able to identify exactly what the problem is.

Assessment includes careful examination under different lighting conditions and from multiple angles. In bright lighting, directional lighting, and side lighting, does the under eye show irregularities, discolourations, or bumps? In some lighting the problem is dramatic; in others it is not visible. This variation in visibility is relevant to the patient’s experience; they may be very aware of the discolouration in certain situations and barely notice it in others. Photography from multiple angles and in different lighting provides documentation and helps the patient see their under eye area as others might see it.

Palpation along the entire under eye region, from the medial canthus laterally towards the junction of the under eye and cheek, allows the clinician to map where volume treatment is present and whether it has distributed evenly or unevenly. Has volume treatment migrated away from the tear trough where it was intended? Is the distribution symmetrical between the two eyes? Are there areas of firmness suggesting volume treatment, and areas of softness suggesting no volume treatment or fluid retention? This tactile map guides the decision about whether selective dissolution of volume treatment in specific areas would help, or whether the entire under eye treatment needs to be removed.

Considering Lymphatic and Tissue Quality Factors

Some patients have a constitutional tendency towards lymphatic congestion and under eye puffiness independent of volume treatment. These patients may have a genetic predisposition to fluid retention, or they may have a history of allergies, sinus issues, or inflammatory conditions that create ongoing under eye swelling. When volume treatment is added to this already compromised area, it can trigger or exacerbate the lymphatic congestion, and the patient may experience worse puffiness than they would have without treatment. Assessment must establish whether the patient has had any under eye swelling or puffiness before volume treatment, and whether the current problem represents a new development or a worsening of something that was already present.

The tissue quality of the under eye area is also relevant. Has the skin become thin, crepey, or poorly hydrated? Are there fine lines that are more prominent now than before volume treatment? Some patients report that under eye treatment treatment actually accelerates the appearance of ageing in the area, creating new fine lines or making existing ones more pronounced. This may be due to the volume treatment disrupting the skin barrier function, or to reactive inflammation, or to the physical effect of volume treatment compressing the delicate skin. If tissue quality has been negatively affected by the volume treatment, this is relevant to the decision about whether to continue with volume treatment, and what alternative approaches might be more suitable.

Darker circles or pigmentation changes are also assessed as part of tissue quality. Have the dark circles improved, worsened, or remained the same? Has the colour of the under eye area changed? Some patients find that their dark circles appear darker or more pronounced after under eye treatment, either because the volume treatment has highlighted the contrast between the treated and untreated areas, or because vascular prominence is now more apparent due to the changed contour. If dark circles are worse rather than better, correction may involve removing the volume treatment entirely rather than trying to refine it.

Assessment of Sensory Changes and Functional Impact

The under eye area contains sensory nerves that may be affected by volume treatment. Some patients report numbness, tingling, or altered sensation after under eye treatment injection. Ask whether sensation has returned to normal, or whether numbness or unusual sensations persist. Has the patient experienced any changes in tear production or eye comfort? Some report that their eyes feel drier after treatment, or that they are more sensitive to wind or light. Others notice that their eyes water more than before. These functional changes are relevant to the decision about whether to continue or dissolve the volume treatment; they significantly impact quality of life and may outweigh any aesthetic benefits.

Blinking and eye closure are also assessed. Some patients report that their eyes do not close completely, or that they experience discomfort when closing the eyes forcefully, after under eye treatment treatment. This is usually temporary, but it is notable because it indicates that the volume treatment may be positioned superficially or laterally in a way that mechanically interferes with normal eye function. If this problem persists, it may be an indication for correction. Some patients also report that their eyes feel “heavy” or “weighted down” after under eye treatment, particularly at the end of the day, and this sensation subsides only partially with time.

Treatment Pathway: Observation and Monitoring

Not all under eye treatment problems require active intervention. If the assessment suggests that the issue is predominantly reactive swelling or fluid retention rather than true excessive volume treatment volume, a period of monitoring may be the most appropriate approach. The patient is counselled that under eye swelling typically takes four to twelve weeks to resolve fully after injection, and that some degree of puffiness may persist at low levels for several months. During this monitoring period, the patient is advised on strategies to minimise swelling: sleeping with the head elevated, avoiding salt and alcohol, staying well hydrated, and using cold compresses or other lymphatic stimulation techniques.

If the problem is primarily related to the patient’s underlying lymphatic constitution rather than to the volume treatment itself, treatment strategies for lymphatic drainage, such as lymphatic massage or manual therapy, may be more helpful than dissolving the volume treatment. Some patients benefit from treatment of underlying sinus or allergic conditions that are contributing to under eye congestion. The volume treatment may remain in place, and the swelling and puffiness may gradually improve as these other factors are addressed. A monitoring approach is conservative and allows time for both the swelling to resolve and for the patient’s perception to stabilise. In many cases, what appeared to be a problem at two or four weeks has substantially improved by twelve weeks.

Treatment Pathway: Staged Dissolution

When dissolution is indicated, it must be performed with particular care in the under eye region because of the delicate structures and high vascularity. Staged dissolution is essential; removing all the volume treatment at once carries a higher risk of tissue injury and reactive inflammation. The first dissolution session removes a portion of the volume treatment, with particular focus on any volume treatment that is placed superficially and contributing to discolouration or texture irregularities. The under eye is reassessed two to three weeks later, and a second dissolution may be performed if needed.

The patient is counselled that dissolution in the under eye area may cause temporary worsening of swelling; the enzyme breaks down the volume treatment, which triggers an inflammatory response, and the under eye may be more puffy for a few days after dissolution than it was before. This acute swelling resolves within a week. The patient is advised to use ice, elevation, and lymphatic drainage strategies aggressively in the days after dissolution to minimise the reactive swelling. Some patients choose to schedule dissolution treatments strategically, such as before a holiday or a period where they will be resting, to allow adequate time for swelling to resolve.

After dissolution, the under eye tissue needs time to settle and stabilise. Swelling that results from the dissolution procedure itself can mask the true outcome of the dissolution. Most clinicians recommend waiting at least two to three weeks between dissolution treatments to allow acute swelling to resolve, and ideally waiting one to two months before making a final assessment of how the eye area looks post correction. During this waiting period, the patient may feel that the under eye area looks worse than it did before dissolution; this is often temporary and results from the residual swelling and the tissue’s adjustment to the removal of volume treatment.

Treatment Pathway: Full Reset and Reassessment

In some cases, the most appropriate approach to under eye treatment correction is a complete reset: dissolution of all or most of the existing volume treatment, and a waiting period of several months before any consideration of retreatment. This pathway is chosen when the problem is significant enough that partial correction is unlikely to be satisfactory, or when there is concern about tissue integrity or chronic complications that would likely recur if new volume treatment is added.

The reset approach has particular value in the under eye region because it allows the tissue to fully recover and settle without any volume treatment present. The patient can experience their natural under eye appearance, which may have changed due to ageing or due to the effects of the previous volume treatment. The original concern that prompted the initial volume treatment, such as hollow dark circles, may prove less bothersome than the complications caused by the volume treatment. In some cases, patients discover that they prefer their natural under eye appearance to any augmented appearance, even with well placed volume treatment, and they choose not to pursue retreatment. This is a valid and respected choice.

The reset timeline also allows the clinician and patient to evaluate whether there are alternative treatments that might be more suitable than volume treatment for that particular patient’s under eye concerns. Some patients are better served by non injectable treatments such as targeted skin care, topical depigmenting agents, or noninvasive aesthetic treatments that address dark circles through skin quality improvement rather than through volume augmentation. The waiting period provides time to explore these alternatives.

What Happens After Under eye treatment is Dissolved

Post dissolution, the under eye area undergoes significant changes over weeks and months. The acute swelling caused by the dissolution procedure itself resolves within one to two weeks. The tissue may appear and feel different; some patients describe it as thinner or more fragile than before treatment. This perceived fragility is usually temporary and reflects the tissue’s reaction to the dissolution process rather than true damage. Fine lines may become more visible immediately after dissolution as the volume that was plumping the skin is removed. This is expected and typically improves as the skin hydrates and stabilises.

The colour of the under eye area may change. If discolouration (Tyndall effect) was present, it resolves as the discoloured volume treatment is broken down. Dark circles that were masked by the volume treatment may become more apparent. Some patients find that their dark circles look worse after dissolution than they did before any treatment, and this can be emotionally disappointing. However, it is also an opportunity to assess whether the dark circles are primarily due to hollowness (which volume treatment can address) or primarily due to vascular prominence and pigmentation (which volume treatment does not help and may worsen).

Lymphatic swelling may persist for several months after dissolution. The area has been disrupted by treatment injection and then by dissolution; the lymphatic system is reactive, and swelling may continue to fluctuate for some time. Continued lymphatic drainage strategies, including elevation, cold application, and manual lymphatic massage, support recovery. Some patients report that their under eye area does not fully return to its pre volume treatment state; there may be persistent mild puffiness or slight skin laxity. These persistent changes reflect the tissue’s reaction to the volume treatment experience and are typically minor compared to the problems that prompted correction.

When Not to Refill the Under Eye Area

A critical consideration in under eye treatment correction is recognising situations where retreatment is not appropriate and where the patient would be better served by accepting their natural under eye appearance or pursuing non injectable alternatives. If the patient’s original problem was chronic lymphatic congestion and swelling that predated the volume treatment, adding new volume treatment is likely to exacerbate the problem again. If the patient has a history of inflammatory responses to volume treatment or other injectable treatments, the under eye area is not an appropriate place to repeat treatment. If the patient’s concern is primarily about dark circles due to vascular prominence or pigmentation rather than hollowness, volume treatment will not address the core problem and may create new complications.

Some patients discover, after the correction process, that they prefer their natural under eye appearance without any volume treatment, even if it includes mild hollowness or dark circles. This preference is valid and should be respected. Not every aesthetic concern requires treatment, and the under eye area in particular carries high risk of complications relative to the benefit provided by augmentation. A patient who has experienced under eye treatment complications and chosen to have them dissolved should be counselled that retreatment carries a risk of similar complications recurring. If they choose to proceed, they do so with full understanding of this risk.

For patients whose under eye concerns are primarily about skin quality, texture, fine lines, or dark circles related to pigmentation rather than volume loss, non injectable treatments may be more appropriate. Topical treatments addressing pigmentation, sun protection to prevent worsening of discolouration, retinoid use to improve skin quality and fine lines, and professional skin treatments such as light based therapies or chemical peels may provide benefit without the risk of volume related complications. A comprehensive consultation explores these alternative approaches before any decision is made to re treat the under eye area with volume treatment.

The No-Filler Strategy for Some Patients

Some patients decide, after under eye treatment correction, that they do not want to pursue retreatment. This decision is often based on the realisation that under eye treatment, despite aiming to improve the appearance, created more problems than it solved. These patients may choose instead to focus on non injectable approaches to addressing their under eye concerns. This is a legitimate and often excellent choice for under eye aesthetics.

The no volume treatment strategy for under eye areas involves accepting the natural changes that come with ageing, and focusing instead on skin quality, sun protection, and treatment of pigmentation or vascular concerns through noninvasive means. Many patients find that this approach addresses their concerns more effectively and safely than volume treatment ever did. Some patients in this category benefit from consistent use of topical products addressing pigmentation or skin quality, from professional aesthetic treatments such as laser or light based therapy targeting discolouration or fine lines, or from comprehensive dermatological care addressing any underlying skin conditions. The under eye area is complex and delicate, and sometimes the best aesthetic approach is conservative management focused on maintaining skin health rather than adding volume.

Psychological Considerations and Emotional Impact

Under eye treatment correction often carries significant emotional weight. Many patients sought volume treatment with the hope of looking rested, refreshed, and more youthful. The discovery that the volume treatment has created complications, or that it has not achieved the hoped for result, can feel like a failure or a setback. Some patients experience regret about the decision to have volume treatment. Others feel anxious about proceeding with correction, worrying that dissolution will make their under eye appearance worse, or that they will regret losing the volume that the volume treatment provided.

These emotional responses are valid and warrant empathetic acknowledgement. The clinician’s role includes helping the patient process their feelings about both the original volume treatment and the correction process. Some patients benefit from taking time to consider their options before committing to a particular correction pathway. Others need reassurance that correction, even if it results in a temporary worsening of appearance, is often the right choice because it addresses the underlying problem of volume treatment related complications. Setting realistic expectations about what post correction appearance will look like, and acknowledging that the aesthetic outcome may not be identical to the pre volume treatment state, helps the patient prepare emotionally for the correction journey.

Realistic Outcome Expectations

The realistic outcome of under eye treatment correction is resolution of the specific complications that prompted correction. If the problem was persistent swelling, the outcome is a return to a more normal state of under eye puffiness, though some baseline puffiness may persist if the patient has a constitutional tendency. If the problem was discolouration, the outcome is resolution of that discolouration and a return to the patient’s natural under eye colour. If the problem was texture irregularities, the outcome is smoothing of those irregularities and a return to normal skin texture.

Patients should not expect their under eye area to look exactly as it did before any volume treatment. The tissue has been altered by the treatment and by the correction process. Some patients note subtle changes in the appearance of the under eye area, such as slightly different contours or slightly different reflectance of light, even after complete dissolution. These subtle changes are typically minor and often not noticed by others. The primary outcome goal is resolution of complications and a return to functional, comfortable tissue that is not causing ongoing distress.

If retreatment is chosen after a full reset period, the outcome expectation is improvement in the specific under eye concern, such as reduction of hollowness or dark circles, achieved with conservative volumes and precise placement in a plane that minimises complications. Realistic expectation is that under eye treatment is a subtle enhancement rather than a dramatic transformation. If the patient’s goal is dramatic visible augmentation of the under eye area, they should be counselled that this carries higher risk of complications and may not be achievable safely in that region. The focus is on quality of result and sustainability rather than on volume or drama.